[1]
M. L. Campos and M. A. Estrin, “Ocrelizumab and its role in the treatment of multiple sclerosis: A systematic review of the literature”, Salud, Ciencia y Tecnología - Serie de Conferencias, vol. 3, p. 924, Jan. 2024, doi: 10.56294/sctconf2024924.